stemcellresources.blogspot.com
"Cancer Stem Cell Resources"
http://stemcellresources.blogspot.com/2007/07/stem-cell-resources.html
Thursday, January 8, 2015. Professional Stem cell Organizations,. Adult Stem Cell Research (ASCR) Network. Australian Stem Cell Centre. Australasian Society for Stem Cell Research (ASSCR). Basel Stem Cell Network (BSCN). Beta Cell Biology Consortium. Canadian Stem Cell Networks. China Stem Cell Network. Columbia University Stem-Cell Consortium. Cancer Stem Cell Consortium (CSCC). Danish Centre for Stem Cell Research. E's - Innovative Medicines Initiative (IMI). European Consortium for Stem Cell Research.
swedegene.se
Pågående genetiska undersökningar
http://www.swedegene.se/index.php/biverkningar-vi-studerar/pagaende-genetiska-undersokningar
Adverse drug reactions to be studied. Läkemedelsutlöst agranulocytos (mycket låga nivåer av vita blodkroppar). Angioödem (slemhinnesvullnad) av ACE-hämmare. Omkring 300 fall kommer att genomgå exomsekvensning och jämföras med motsvarande analyser från friska individer. Resultat förväntas under slutet av 2016. Omkring 110 fall har genomgått helgenomsanalys och målet är att samla in omkring 300 fall innan resultaten jämförs med motsvarande analyser från friska individer. Allvarliga hudreaktioner (s.k&#...
pharmaindustrypharmacovigilance.blogspot.com
Pharma Industry & Pharmacovigilance: Strategies for Emerging Markets from PHARMACEUTICAL EXECUTIVE
http://pharmaindustrypharmacovigilance.blogspot.com/2010/08/strategies-for-emerging-markets-from.html
Pharma Industry and Pharmacovigilance. Blog Mission and Vision. With great changes in Pharmacovigilance, the most recent news and innovations are critical to our goal of maintaining patient safety in the 21st Century. A series of links are provided to take the reader directly to important sites of innovation, regulation and knowledge. My overall aim is to raise awareness and consistency for readers of this blog. Sunday, August 22, 2010. Strategies for Emerging Markets from PHARMACEUTICAL EXECUTIVE. Pithy...
pharmaindustrypharmacovigilance.blogspot.com
Pharma Industry & Pharmacovigilance: Social Media and Pharmacovigilance - DIA
http://pharmaindustrypharmacovigilance.blogspot.com/2010/06/social-media-and-pharmacovigilance-dia.html
Pharma Industry and Pharmacovigilance. Blog Mission and Vision. With great changes in Pharmacovigilance, the most recent news and innovations are critical to our goal of maintaining patient safety in the 21st Century. A series of links are provided to take the reader directly to important sites of innovation, regulation and knowledge. My overall aim is to raise awareness and consistency for readers of this blog. Saturday, June 5, 2010. Social Media and Pharmacovigilance - DIA. Edwin J Tucker MD. Ernst an...
pharmaindustrypharmacovigilance.blogspot.com
Pharma Industry & Pharmacovigilance: Regulations.gov - very helpful site in the US
http://pharmaindustrypharmacovigilance.blogspot.com/2010/08/regulationsgov.html
Pharma Industry and Pharmacovigilance. Blog Mission and Vision. With great changes in Pharmacovigilance, the most recent news and innovations are critical to our goal of maintaining patient safety in the 21st Century. A series of links are provided to take the reader directly to important sites of innovation, regulation and knowledge. My overall aim is to raise awareness and consistency for readers of this blog. Sunday, August 22, 2010. Regulations.gov - very helpful site in the US. Edwin J Tucker MD.
swedegene.se
Samverkan
http://www.swedegene.se/index.php/om-swedegene/priser
Adverse drug reactions to be studied. Vår forskargrupp samarbetar med flera olika internationella forskargrupper för att snabbare kunna samla in tillräckligt många fall av olika typer av sällsynta biverkningar. Flera av dessa ingår i projektet. Andra samarbetspartners är det USA-baserade projektet. Där fokus ligger på läkemedelsutlösta leverskador, allvarliga hudreaktioner och osteonekros (bensönderfall) i käken relaterat till bisfosfonater (läkemedel mot benskörhet). I Sverige samarbetar vi med spec...
omixon.com
Pharmacoenomics | NGS HLA Typing | Omixon
http://www.omixon.com/hla-typing-for-pharmacogenomics
OMIXON – NGS for HLA. Skip to primary content. Skip to secondary content. HLA plays an important role in the pathology of adverse drug response. Omixon Target HLA Typing software gives high resolution results with whole genome. Or with RNA seq. Data (as well as with targeted data). There is no need to be an expert in NGS analysis to use the tool. According to the International SAE (Serious Adverse Events) Consortium. MHC – the major histocompatibility complex is a set of cell surface molecules enco...
clinicaltrialscongress.blogspot.com
Clinical Trials Congress: December 2008
http://clinicaltrialscongress.blogspot.com/2008_12_01_archive.html
Wednesday, December 24, 2008. Happy Holidays from CTC. We will be taking some much needed time off for the holidays. We'd like to thank you for your readership and we encourage you to check back with us next year for more innovative thought, perspective and news surrounding the world of clinical trials. We wish you a joyous holiday season! Labels: Clinical Trials Congress. Tuesday, December 23, 2008. Hard times leads to more patients for clinical trials. A recent news report. Posted by Jenny Pereira.
pharmaindustrypharmacovigilance.blogspot.com
Pharma Industry & Pharmacovigilance: August 2010
http://pharmaindustrypharmacovigilance.blogspot.com/2010_08_01_archive.html
Pharma Industry and Pharmacovigilance. Blog Mission and Vision. With great changes in Pharmacovigilance, the most recent news and innovations are critical to our goal of maintaining patient safety in the 21st Century. A series of links are provided to take the reader directly to important sites of innovation, regulation and knowledge. My overall aim is to raise awareness and consistency for readers of this blog. Sunday, August 22, 2010. Strategies for Emerging Markets from PHARMACEUTICAL EXECUTIVE. Pithy...
